Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.
Access small cell lung cancer specialists in Peoria at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer treatment provided free
This is an open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants. The main goals of this study are to: * Evaluate the efficacy of BMS-986489 vs durvalumab * Evaluate the safety profile of BMS-986489
Sponsor: SCRI Development Innovations, LLC
Check if you qualify for this small cell lung cancer clinical trial in Peoria, IL
If you're searching for small cell lung cancer treatment options in Peoria, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.